Nanoform Finland Oyj (STO:NANOFS)

Sweden · Delayed Price · Currency is SEK

7.39

+0.33 (4.67%)

At close: Mar 4, 2026

Revenue by Segment

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Expert Services in Nanotechnology and Drug Particle Engineering	5.02M	3.66M	2.57M	3.49M	1.95M
Expert Services in Nanotechnology and Drug Particle Engineering Growth	37.10%	42.72%	-26.41%	78.42%	178.38%
Total	5.02M	3.66M	2.57M	3.49M	1.95M
Total Growth	37.10%	42.72%	-26.41%	78.42%	178.38%

Revenue by Geography

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Europe	2.00M	1.89M	1.46M	1.96M	1.56M
Europe Growth	5.71%	29.20%	-25.37%	25.90%	184.88%
United States	1.07M	791.00K	1.10M	1.53M	396.77K
United States Growth	35.52%	-28.28%	-27.73%	284.63%	183.57%
Other	475.00K	96.00K	-	-	-
Other Growth	394.79%	-	-	-	-
Total	3.55M	2.78M	2.57M	3.49M	1.95M
Total Growth	27.65%	8.24%	-26.41%	78.42%	184.61%

Source: S&P Global Market Intelligence.